Solution behavior of a novel biopharmaceutical drug candidate: A gonadotropin-toxin conjugate

Drug Development and Industrial Pharmacy

Volumn 32, Issue 10, 2006, Pages 1175-1184

  Katayama, Derrick S ^a   Manning, Mark Cornell ^a,c   Jarosz, Paul ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b GonexPets   (United States)

^c Legacy BioDesign LLC   (United States)

Author keywords

Peptide and protein conjugate; Solution structure and stability

Indexed keywords

GONADORELIN POKEWEED ANTIVIRUS PROTEIN CONJUGATE; HORMONE DERIVATIVE; PROTEIN DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); DRUG CONFORMATION; DRUG CONJUGATION; DRUG DEGRADATION; DRUG STABILITY; EXPERIMENTAL DESIGN; HEAT TREATMENT; HEATING; ION EXCHANGE CHROMATOGRAPHY; PH MEASUREMENT; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; STRUCTURE ANALYSIS;

DRUG DESIGN; DRUG STABILITY; FREEZING; GONADOTROPIN-RELEASING HORMONE; HEAT; HYDROGEN-ION CONCENTRATION; MULTIPROTEIN COMPLEXES; N-GLYCOSYL HYDROLASES; PLANT PROTEINS; PROTEIN DENATURATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS;

EID: 33750858836     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600815194     Document Type: Article

References (9)

1. Ago, H., Kataoka, J., Tsuge, H., Habuka, N., Inagaki, E., & Noma, M., et al. (1994). X-ray structure of a pokeweed antiviral protein, coded by a new genomic clone, at 0.23 nm resolution-a model structure provides a suitable electrostatic-field for substrate-binding. European Journal of Biochemistry, 225, 369-374.
2. Blomgren, H., Einhorn, S., & Vonstedingk, L. V., & Wasserman, J. (1981). Influence of interferon on poke weed mitogen triggered Ig-secretion by human-lymphocytes in vitro. Journal of Interferon Research, 1, 513-519.
3. Li, H. M., Zeng, Z. H., Hu, Z., & Wang, D. C. (1998). Crystallization and preliminary crystallographic analyses of pokeweed antiviral protein from seeds. Acta Crystallographica Section D-Biological Crystallography, 54, 137-139.
4. Lodge, J. K., Kaniewski, W. K., & Tumer, N. E. (1993). Broad-spectrum virus-resistance in transgenic plants expressing pokeweed antiviral protein. Proceedings of the National Academy of Sciences of the United States of America, 90, 7089-7093.
5. Middaugh, C. R., Tisel, W. A., Haire, R. N., & Rosenberg, A. (1979). Determination of the apparent thermodynamic activities of saturated protein solutions. Journal of Biological Chemistry, 254, 367-370.
6. Oonk, H. B., Turkstra, J. A., Schaaper, W. M., Erkens, J. H. F., Schuitemakerde Weerd, M. H., van Nes, A., Verheijden, J. H. M., & Meloen, R. H. (1998). New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH. Vaccine, 16, 1074-1082.
7. Ragone, R., Colonna, G., Balestrieri, C., Servillo, L., & Irace, G. (1984). Determination of tyrosine exposure in proteins by 2nd-derivative spectroscopy. Biochemistry, 23, 1871-1875.
8. Rodes, T. L., 3rd, & Irvin, J. D. (1981). Reversal of the inhibitory effects of the pokeweed antiviral protein upon protein synthesis. Biochim. Biophys. Acta, 652, 160-167.
9. Schlick, J., Dulieu, P., Desvoyes, B., Adami, P., Radom, J., & Jouvenot, M. (2000). Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines. FEBS Lett., 472, 241-246.